LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article ; Online: Severe Acute Respiratory Syndrome-Coronavirus-2 Antibody Status at the Time of Delivery and the Risk of Preeclampsia.

    Portmann-Baracco, Arianna S / Alcorta-Proaño, Rodrigo G / Nuñez-Mochizaki, Claudia / Webb, Camille M / Trelles, Juan / Caparo, Carlos / La Rosa, Mauricio F

    American journal of perinatology

    2023  

    Abstract: Objective:  Our objective was to evaluate the association between severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) serologic status in immunologically naive patients and the risk of preeclampsia at the time of delivery.: Study design:  We ...

    Abstract Objective:  Our objective was to evaluate the association between severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) serologic status in immunologically naive patients and the risk of preeclampsia at the time of delivery.
    Study design:  We conducted a retrospective cohort study of pregnant patients admitted to our institution from August 1 to September 30, 2020. We recorded maternal medical and obstetric characteristics and SARS-CoV-2 serologic status. Our primary outcome was the incidence of preeclampsia. Antibody testing was performed, and patients were classified into seropositive groups: immunoglobulin (Ig)G + , IgM + , or both IgG+ and IgM + . Bivariate and multivariable analyses were performed.
    Results:  We included 275 patients that were negative for SARS-CoV-2 antibodies, and 165 that were positive. Seropositivity was not associated with higher rates of preeclampsia (
    Conclusion:  We found that in an obstetric population, there was no association between SARS-CoV-2 antibody status and the risk of preeclampsia.
    Key points: · Pregnant people with acute COVID-19 are at an increased risk of developing preeclampsia.. · Seroconversion during pregnancy was not associated with an increased risk of preeclampsia.. · Further study regarding the timing of infection and its association with preeclampsia is necessary..
    Language English
    Publishing date 2023-06-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605671-4
    ISSN 1098-8785 ; 0735-1631
    ISSN (online) 1098-8785
    ISSN 0735-1631
    DOI 10.1055/a-2099-8758
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Reply to "Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19".

    Accinelli, Roberto Alfonso / Portmann-Baracco, Arianna / Bryce-Alberti, Mayte

    Archivos de bronconeumologia

    2020  Volume 56, Issue 12, Page(s) 833

    MeSH term(s) Anti-Inflammatory Agents/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19 ; Hospitalization ; Humans ; Pulmonary Disease, Chronic Obstructive/drug therapy ; SARS-CoV-2
    Chemical Substances Anti-Inflammatory Agents ; Antiviral Agents
    Language English
    Publishing date 2020-11-06
    Document type Letter ; Comment
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbr.2020.11.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: El Tratamiento con Bloqueadores del Sistema Renina-Angiotensina-Aldosterona no debe suspenderse tras la Infección por SARS-CoV-2.

    Bryce-Moncloa, Alfonso / Portmann-Baracco, Arianna / Bryce-Alberti, Mayte

    Archivos peruanos de cardiologia y cirugia cardiovascular

    2020  Volume 1, Issue 2, Page(s) 64–66

    Title translation Renin-Angiotensin-Aldosterone System Inhibitors should not be suspended due to SARS-CoV-2 Infection.
    Language Spanish
    Publishing date 2020-06-29
    Publishing country Peru
    Document type Editorial
    ISSN 2708-7212
    ISSN (online) 2708-7212
    DOI 10.47487/apcyccv.v1i2.62
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19.

    Portmann-Baracco, Arianna / Bryce-Alberti, Mayte / Accinelli, Roberto Alfonso

    Archivos de bronconeumologia

    2020  Volume 56, Issue 12, Page(s) 831

    Title translation Propiedades antivirales y antiinflamatorias de ivermectina y su potencial uso en COVID-19.
    MeSH term(s) Anti-Inflammatory Agents/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Humans ; Ivermectin/therapeutic use ; SARS-CoV-2
    Chemical Substances Anti-Inflammatory Agents ; Antiviral Agents ; Ivermectin (70288-86-7)
    Keywords covid19
    Language Spanish
    Publishing date 2020-07-07
    Document type Letter
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2020.06.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Reply to "Antiviral and anti-inflammatory properties of ivermectinand its potential use in COVID-19".

    Accinelli, Roberto Alfonso / Portmann-Baracco, Arianna / Bryce-Alberti, Mayte

    Archivos de bronconeumologia

    2020  Volume 56, Issue 12, Page(s) 833

    Title translation En respuesta a «Propiedades antivirales y antiinflamatorias de ivermectina y su potencial uso en COVID-19».
    MeSH term(s) Anti-Inflammatory Agents/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Humans ; Ivermectin/therapeutic use ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2
    Chemical Substances Anti-Inflammatory Agents ; Antiviral Agents ; Ivermectin (70288-86-7)
    Language Spanish
    Publishing date 2020-09-23
    Publishing country Spain
    Document type Letter ; Comment
    ZDB-ID 2591346-3
    ISSN 2173-5751 ; 2173-5751
    ISSN (online) 2173-5751
    ISSN 2173-5751
    DOI 10.1016/j.arbres.2020.09.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: El tratamiento con bloqueadores del sistema Renina-Angiotensina-Aldosterona no debe suspenderse tras la infección por SARS-CoV-2

    Alfonso Bryce / Arianna Portmann-Baracco / Mayte Bryce-Alberti

    Archivos Peruanos de Cardiología y Cirugía Cardiovascular, Vol 1, Iss 2, Pp 64-

    2020  Volume 66

    Keywords Surgery ; RD1-811 ; Medicine (General) ; R5-920
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher Instituto Nacional Cardiovascular - INCOR
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: Tocilizumab in COVID-19: enthusiasm vs. evidence.

    Zena-Huancas, Paola / Leon-Jimenez, Franco / Bryce-Alberti, Mayte / Portmann-Baracco, Arianna

    Lung India : official organ of Indian Chest Society

    2021  Volume 38, Issue 6, Page(s) 574–576

    Abstract: Based on the pathophysiological characterization of COVID-19, initial studies suggested the use of tocilizumab (TCZ), a recombinant humanized monoclonal antibody of the immunoglobulin G1 class, for management of the cytokine storm witnessed in severe ... ...

    Abstract Based on the pathophysiological characterization of COVID-19, initial studies suggested the use of tocilizumab (TCZ), a recombinant humanized monoclonal antibody of the immunoglobulin G1 class, for management of the cytokine storm witnessed in severe cases. Thus, we decided to present a case series of 18 patients with severe COVID-19 treated with TCZ at our hospital. Our results coincide with the fact that the routine use of TCZ in severe COVID-19 is not robustly supported. We believe that the efficacy and safety of this drug and other related molecules should be validated in large randomized clinical trials.
    Language English
    Publishing date 2021-11-08
    Publishing country India
    Document type Case Reports
    ZDB-ID 2410801-7
    ISSN 0974-598X ; 0970-2113
    ISSN (online) 0974-598X
    ISSN 0970-2113
    DOI 10.4103/lungindia.lungindia_766_20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Complicaciones cardiovasculares agudas en una población peruana de pacientes oncológicos.

    Valenzuela-Rodríguez, Germán / Lescano-Alva, Miguel / Bryce-Alberti, Mayte / Portmann-Baracco, Arianna / Prudencio-León, Walter

    Archivos peruanos de cardiologia y cirugia cardiovascular

    2022  Volume 3, Issue 1, Page(s) 1–7

    Abstract: Objective: To know the most frequent acute cardiovascular complications in a Peruvian population of oncologic patients.: Materials and methods: Retrospective, descriptive study of oncologic patients treated at Clinica Delgado between January 2014 and ...

    Title translation Acute cardiovascular complications in a Peruvian population of oncology patients.
    Abstract Objective: To know the most frequent acute cardiovascular complications in a Peruvian population of oncologic patients.
    Materials and methods: Retrospective, descriptive study of oncologic patients treated at Clinica Delgado between January 2014 and December 2019, from which the subgroup with the seven most prevalent cancers at the national level was selected according to information from Globocan 2018. Additionally, we evaluated the epidemiology of patients with cardiovascular complications that conditioned their hospitalization or were detected during this, calculating their cardiovascular risk according to Hermann and SCORE risk scales.
    Results: Forty-four patients had complications; 27 (61.4%) were hospitalized due to acute cardiovascular causes. The mean age of this subgroup was 69.88 years (SD 12.77), and 22 (81.5%) were older than 60 years. Fourteen (51.9%) were male. According to the Hermann scale, 33.3% had intermediate-risk and 14.9% had a high or very high risk. According to the SCORE scale, 62.97% had an intermediate-risk and 7.40% high risk. The most common acute cardiovascular complications were deep vein thrombosis and ischemic stroke (66.65%). One patient (3.7%) reported previous cardiovascular disease. Four patients (14.8%) had a fatal outcome during hospitalization. The median length of hospitalization was five days.
    Conclusions: We present the cases of acute cardiovascular complications in a population of oncologic patients and their vascular risk according to Hermann and SCORE scales. The most common complications were deep vein thrombosis (48.14%), stroke (18.51%), and myocardial infarction (14.81%).
    Language Spanish
    Publishing date 2022-03-31
    Publishing country Peru
    Document type English Abstract ; Journal Article
    ISSN 2708-7212
    ISSN (online) 2708-7212
    DOI 10.47487/apcyccv.v3i1.192
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Appendicular dedifferentiated chondrosarcoma: A management and survival study from the SEER database.

    Gonzalez, Marcos R / Bryce-Alberti, Mayte / Portmann-Baracco, Arianna / Inchaustegui, Maria L / Castillo-Flores, Samy / Pretell-Mazzini, Juan

    Journal of bone oncology

    2022  Volume 37, Page(s) 100456

    Abstract: Introduction: Dedifferentiated chondrosarcoma (DDC) is an aggressive osseous neoplasm with a dismal prognosis. Treatment commonly involves limb-salvage surgery or amputation. In patients with appendicular DDC, we sought to describe demographic, clinical ...

    Abstract Introduction: Dedifferentiated chondrosarcoma (DDC) is an aggressive osseous neoplasm with a dismal prognosis. Treatment commonly involves limb-salvage surgery or amputation. In patients with appendicular DDC, we sought to describe demographic, clinical and treatment characteristics (1), analyze risk factors for metastasis (2) and overall death (3), and assess survival rates by treatment (4).
    Materials and methods: Two-hundred-and-five patients from the SEER Database were included in our analysis. Demographic, clinical and treatment variables were analyzed. Multivariate regression was performed to identify risk factors. Survival analysis was performed using the Kaplan-Meier method.
    Results: Fifty-one (24.9 %) of the patients included presented metastasis at diagnosis. The most common locations were the lungs, other sites, and bone. Surgery to the primary site was more common in patients without metastasis (94.2 %) than those with (78.2 %); limb-salvage procedures were more common than amputations. Tumors >8 cm (T2) and those discontinuous (T3) were more likely to present metastasis at diagnosis (OR = 2.54, p = 0.043 and OR = 7.4, p = 0.008, respectively). Female gender was found to be a protective factor for overall death on crude analysis (OR = 0.33, p = 0.019). Metastases to sites other than the lungs (M1b) had the highest risk of overall death (OR = 49, p = 0.01). Combination of surgery and chemotherapy showed a trend towards higher overall survival in non-metastatic patients (p = 0.1069 and p = 0.1703).
    Conclusions: Appendicular DDC displays a high metastatic rate and low survival rates. The most common procedure is a limb-salvage surgery. Tumor size increases the risk of presenting metastases at diagnosis and female gender is a protective factor against death.
    Language English
    Publishing date 2022-10-08
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2212-1366
    ISSN 2212-1366
    DOI 10.1016/j.jbo.2022.100456
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Treatment and survival outcomes in metastatic Merkel cell carcinoma: Analysis of 2010 patients from the SEER database.

    Gonzalez, Marcos R / Bryce-Alberti, Mayte / Portmann-Baracco, Arianna / Castillo-Flores, Samy / Pretell-Mazzini, Juan

    Cancer treatment and research communications

    2022  Volume 33, Page(s) 100665

    Abstract: Introduction: Merkel cell carcinoma (MCC) is an aggressive cutaneous cancer that frequently compromises the lymph nodes (LN) and distal organs. We sought to describe clinical and demographic characteristics of affected patients, analyze risk factors for ...

    Abstract Introduction: Merkel cell carcinoma (MCC) is an aggressive cutaneous cancer that frequently compromises the lymph nodes (LN) and distal organs. We sought to describe clinical and demographic characteristics of affected patients, analyze risk factors for LN compromise, metastasis, and death, and evaluate their impact on survival.
    Materials and methods: Patients with MCC were retrieved from the SEER database. Demographic, clinical and treatment data were analyzed. Logistic and Cox proportional hazard regression were used to analyze risk factors. Survival analysis was done with the Kaplan-Meier method.
    Results: A total of 2010 patients were included, among which 288 (14.33%) had distant metastases at diagnosis. LN involvement occurred in 45.8% and 20.1% of patients with and without distant metastasis, respectively. Males were more likely to present LN compromise (OR = 1.33, p<0.001). Tumors >10 mm showed a significantly higher risk for LN involvement and distant metastasis, with those >20 mm showing the highest risk (OR = 2.76 p<0.001 and OR = 8.88 p<0.001 respectively). Location of the tumor in the trunk was a protective factor for overall death (OR = 0.27), while LN compromise was a risk factor (OR = 3.12). Only history of previous malignancy significantly affected disease-specific death (OR = 0.32, p = 0.01). One-year survival was 79.7% and 38.2% for patients with regional LN disease and distant metastasis, respectively.
    Conclusion: MCC is an aggressive cancer with high rates of LN involvement and distant metastases. Male gender and tumor size were risk factors for regional LN and metastatic disease. Tumor location in the trunk decrease the risk of overall death, while LN involvement increased it.
    Language English
    Publishing date 2022-11-24
    Publishing country England
    Document type Journal Article
    ISSN 2468-2942
    ISSN (online) 2468-2942
    DOI 10.1016/j.ctarc.2022.100665
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top